Slingshot members are tracking this event:
Merck's (MRK) Marketing Authorization Application (MAA) for Avelumab in Rare Skin Cancer Validated by European Medicines Agency (EMA)
Slingshot Insights Explained
Oct 31, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Avelumab, Marketing Authorization Application, Maa, Rare Skin Cancer, European Medicines Agency